Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
J Med Chem. 2023 Jul 13;66(13):9130-9146. doi: 10.1021/acs.jmedchem.3c00737. Epub 2023 Jul 2.
The choice of an appropriate electrophile is crucial in the design of targeted covalent inhibitors (TCIs). In this report, we systematically investigated the glutathione (GSH) reactivity of various haloacetamides and the aqueous stability of their thiol adducts. Our findings revealed that dihaloacetamides cover a broad range of GSH reactivity depending on the combination of the halogen atoms and the structure of the amine scaffold. Among the dihaloacetamides, dichloroacetamide (DCA) exhibited slightly lower GSH reactivity than chlorofluoroacetamide (CFA). The DCA-thiol adduct is readily hydrolyzed under aqueous conditions, but it can stably exist in the solvent-sequestered binding pocket of the protein. These reactivity profiles of DCA were successfully exploited in the design of TCIs targeting noncatalytic cysteines of KRAS and EGFR. These inhibitors exhibited strong antiproliferative activities against cancer cells. Our findings provide valuable insights for designing dihaloacetamide-based reversible covalent inhibitors.
在靶向共价抑制剂 (TCI) 的设计中,选择合适的亲电试剂至关重要。在本报告中,我们系统地研究了各种卤代乙酰胺与谷胱甘肽 (GSH) 的反应性及其巯基加合物在水中的稳定性。我们的研究结果表明,二卤代乙酰胺的 GSH 反应性范围很广,具体取决于卤素原子的组合和胺骨架的结构。在二卤代乙酰胺中,二氯乙酰胺 (DCA) 的 GSH 反应性略低于氯氟乙酰胺 (CFA)。DCA-硫醇加合物在水相条件下容易水解,但在蛋白质的溶剂隔离结合口袋中可以稳定存在。这些 DCA 的反应性特征成功地应用于针对 KRAS 和 EGFR 的非催化半胱氨酸的 TCI 的设计中。这些抑制剂对癌细胞表现出强烈的抗增殖活性。我们的研究结果为设计基于二卤代乙酰胺的可逆共价抑制剂提供了有价值的见解。